GODAVARI BIOREFINERIES L
Latest filings
Next results: Wed, 4 Nov · Financial Results- Godavari BioRefineries schedules Q2 and H1 FY27 earnings call · Board & Shareholder Meetings
- Board meeting set for November 4 to approve Q2 and H1 results · Results
- Newspaper notice on SEBI special window for physical share transfer · Compliance
Snapshot
What the business is, and whether it's a good one at a fair price.
Operates an integrated biorefinery complex at Sameerwadi that converts sugarcane and grain into four product streams. Sugar is the largest revenue contributor at ₹1,279.45 crore (47.2% of segment revenue), followed by Distillery at ₹663.65 crore (24.5%), Bio-Based Chemicals at ₹577.99 crore (21.3%), and Cogeneration of power from bagasse at ₹160.28 crore (5.9%). The Distillery segment runs a 600 KLPD sugarcane-based ethanol plant and commissioned a 200 KLPD grain-based distillery on June 29, 2026, giving the business dual-feedstock capability. Bio-Based Chemicals is the most profitable segment by EBIT (₹36.31 crore) and the focus of capital allocation, with specialty chemicals now forming 62% of the chemical basket per management. Other revenue lines include a consumer brand called Jivana (over ₹100 crore in 9M FY26) and drug-discovery work via US subsidiary Sathgen Therapeutics. The largest cost line is materials at 74.9% of revenue, reflecting dependence on sugarcane, grains and chemical feedstocks, with overall EBITDA margin of 5.44% in FY26.
Scorecard
Measured from the filed financials, judged against its Fast Moving Consumer Goods peers · as of FY26 — not investment advice
Strengths
Nothing stands out in the filed numbers.Concerns
Charts
How has the market priced it — with filings on the timeline?
GODAVARIB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from GODAVARI BIOREFINERIES L's filed financials and exchange disclosures
What does GODAVARI BIOREFINERIES L do?
GODAVARI BIOREFINERIES L is a Diversified FMCG company listed on NSE and BSE, trading under the symbol GODAVARIB.
Is GODAVARI BIOREFINERIES L profitable?
Yes. Over the trailing twelve months GODAVARI BIOREFINERIES L reported a net profit of ₹0.23 Cr on revenue of ₹2,013 Cr.
Does GODAVARI BIOREFINERIES L pay a dividend?
Not in the latest reported year — GODAVARI BIOREFINERIES L's dividend payout for FY26 was nil.
Is GODAVARI BIOREFINERIES L debt-free?
No. It reported borrowings of ₹530 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹515 Cr after cash. Debt stands at 0.67× equity. That is higher than 74% of its 281 Fast Moving Consumer Goods peers.
Is GODAVARI BIOREFINERIES L expensive compared with its peers?
On trailing P/E, GODAVARI BIOREFINERIES L ranks 278 of 278 in Fast Moving Consumer Goods — cheaper than 0% of them, against an industry median of 17.7×. This is a position, not a valuation judgement.
How much does the GODAVARI BIOREFINERIES L share price move in a day?
On a typical session GODAVARI BIOREFINERIES L moves 1.65% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.
When are GODAVARI BIOREFINERIES L's next results?
Financial Results on Wed, 4 Nov. MarketPing alerts you on WhatsApp the moment the filing lands.
Where can I track GODAVARI BIOREFINERIES L's announcements?
Every NSE and BSE filing by GODAVARI BIOREFINERIES L appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.